Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium

Author:

Pettersen Erik O.1,Ebbesen Peter12,Gieling Roben G.3,Williams Kaye J.3,Dubois Ludwig3,Lambin Philippe4,Ward Carol5,Meehan James5,Kunkler Ian H.5,Langdon Simon P.5,Ree Anne H.6,Flatmark Kjersti6,Lyng Heidi6,Calzada Maria J.78,Peso Luis del78,Landazuri Manuel O.78,Görlach Agnes9,Flamm Hubert10,Kieninger Jochen10,Urban Gerald10,Weltin Andreas1011,Singleton Dean C.12,Haider Syed12,Buffa Francesca M.12,Harris Adrian L.12,Scozzafava Andrea13,Supuran Claudiu T.14,Moser Isabella11,Jobst Gerhard11,Busk Morten15,Toustrup Kasper15,Overgaard Jens15,Alsner Jan15,Pouyssegur Jacques1617,Chiche Johanna16,Mazure Nathalie16,Marchiq Ibtissam16,Parks Scott1617,Ahmed Afshan18,Ashcroft Margaret18,Pastorekova Silvia19,Cao Yihai20,Rouschop Kasper M.4,Wouters Brad G.421,Koritzinsky Marianne421,Mujcic Hilda21,Cojocari Dan21

Affiliation:

1. Department of Physics, University of Oslo, Oslo, Norway,

2. Laboratory for Stem Cell Research, Department of Health Science and Technology, Aalborg University, Aalborg, Denmark,

3. Manchester Pharmacy School, University of Manchester, Manchester, UK,

4. Department of Radiation Oncology (MaastRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands,

5. Western General Hospital, University of Edinburgh, Edinburgh, UK,

6. Oslo University Hospital, Institute for Cancer Research, Oslo, Norway,

7. Hospital University Princesa, Madrid, Spain,

8. Department of Medicine, Catedratico de Immunologica, Universidad Autonoma Madrid, Madrid, Spain,

9. German Heart Center, Technical University Munich, Munich, Germany,

10. Department of Microsystems Engineering, IMTEK, University of Freiburg, Freiburg, Germany,

11. Jobst Technologies GmbH, Freiburg, Germany,

12. CRUK Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Headington, Oxford, UK,

13. Laboratorio di Chimica Bioinorganica, Polo Scientifico, Università degli Studi di Firenze, Sesto Fiorentino, Florence, Italy,

14. Neurofarba Department, Section of Pharmaceutical and Nutriceutical Sciences, Università degli Studi di Firenze, Sesto Fiorentino, Florence, Italy,

15. Department of Experimental Clinical Oncology, Aarhus University Hospital (AUH), Aarhus, Denmark,

16. CNRS, IRCAN, University of Nice, Nice, France,

17. Centre Scientifique de Monaco, MC, Monaco,

18. The Rayne Instutute, University College London, London, UK,

19. Institute of Virology, Slovak Academy of Sciences, Bratislava, Slovakia,

20. Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden, and

21. Princess Margaret Cancer Centre and Campbell Family Institute for Cancer Research, University Health Network, Toronto, Ontario, Canada

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Cited by 99 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3